Close
Help




JOURNAL

Clinical Medicine Insights: Gastroenterology

Proton Pump Inhibitor use in Hospitalized Patients: Is Overutilization Becoming a Problem?

Submit a Paper


Clinical Medicine Insights: Gastroenterology 2012:5 65-76

Review

Published on 15 Oct 2012

DOI: 10.4137/CGast.S9588


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Insights: Gastroenterology

Abstract

Proton pump inhibitors (PPIs) are among the most common classes of medications prescribed. Though they were previously thought of as safe, recent literature has shown risks associated with their use including increased risk for Clostridium difficile infection, pneumonia, and fractures. Due to these risks, it is important to determine if PPIs are being used appropriately. This review evaluates seven studies in hospitalized patients. Additionally, this review evaluates literature pertaining to recently discovered adverse reactions; all studies found PPIs are being overutilized. Findings highlight the importance of evaluating appropriate therapy with these agents and recommending discontinuation if a proper indication does not exist.



Downloads

PDF  (487.81 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML

PMC HTML


Sharing


What Your Colleagues Say About Clinical Medicine Insights: Gastroenterology
I had a really positive experience publishing in Clinical Medicine Insights: Gastroenterology.  The submission process is easy and friendly.  The review process is very accurate with a considerable quantity of reviewers who give helpful and reasonable suggestions.  The staff are professional and gives prompt email responses.  I recommend colleagues to consider publishing with Libertas Academica.
Dr Vincenzo Neri (University of Foggia, Foggia, Italy)
More Testimonials

Quick Links


New article and journal news notification services
Email Alerts RSS Feeds
Facebook Google+ Twitter
Pinterest Tumblr YouTube